Tomasz (Tom) Beer

Professor

  • 15268 Citations
  • 55 h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Tomasz (Tom) Beer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • CALCITRIOL IN RECURRENT PROSTATE CANCER

    Beer, T. (. & Henner, W.

    National Institutes of Health

    9/30/999/29/03

    Project: Research project

  • Research Output

    Association between New Unconfirmed Bone Lesions and Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials

    Armstrong, A. J., Al-Adhami, M., Lin, P., Parli, T., Sugg, J., Steinberg, J., Tombal, B., Sternberg, C. N., De Bono, J., Scher, H. I. & Beer, T. M., Feb 2020, In : JAMA Oncology. 6, 2, p. 217-225 9 p.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

    Kapoor, R., Deek, M. P., McIntyre, R., Raman, N., Kummerlowe, M., Chen, I., Gaver, M., Wang, H., Denmeade, S., Lotan, T., Paller, C., Markowski, M., Carducci, M., Eisenberger, M., Beer, T. M., Song, D. Y., Deweese, T. L., Hearn, J. W., Greco, S., Deville, C. & 7 others, Desai, N. B., Heath, E. I., Liauw, S., Spratt, D. E., Hung, A. Y., Antonarakis, E. S. & Tran, P. T., Jun 13 2019, In : BMC cancer. 19, 1, 572.

    Research output: Contribution to journalArticle

    Open Access
  • Combining options in metastatic prostate cancer

    Kopp, R. & Beer, T. T., Jan 1 2019, In : Nature Reviews Urology.

    Research output: Contribution to journalComment/debate

  • Correction: Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer (Clinical Cancer Research (2019) 25 (52-63) DOI: 10.1158/1078-0432.CCR-18-1589)

    Ferrari, A. C., Alumkal, J. J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. M., Apr 15 2019, In : Clinical Cancer Research. 25, 8, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer

    Ferrari, A. C., Alumkal, J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. T., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 52-63 12 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations